Oxacillin-induced lysis of Staphylococcus aureus.
Six clinical isolates of Staphylococcus aureus were compared for their relative susceptibilities to the killing effects of oxacillin. Three of the strains had minimum bactericidal concentrations which were >10 times the minimum bacteriostatic concentration for this antibiotic and were designated tolerant (Tol(+)). The other strains had minimum bactericidal concentrations which were comparable to the minimum bacteriostatic concentration (Tol(-)). Lysis curves of these strains revealed that the Tol(+) strains exhibited a diminished rate of lysis when inhibited by oxacillin. This reduced rate of lysis was reflected also in a reduced rate of viability loss when the cells were exposed to oxacillin. During log growth the uptake of [(14)C]glycerol by Tol(+) cells was 1.5-fold greater than that by Tol(-) cells. Glycerol-labeled cells of each phenotype secreted radioactivity when inhibited by oxacillin. However, the Tol(+) strains released over twice as much label as the Tol(-) strains. No difference in the proportion of lipid secreted by the two phenotypes was found. The behavior of 60 to 65% of the labeled material released by inhibited cells during both sodium dodecyl sulfate gel electrophoresis and Sepharose 6B chromatography corresponded to that of lipoteichoic acid. When the major component of secreted material was added to oxacillin-inhibited Tol(-) strains, an inhibition of the lytic response was observed. These results suggest that oxacillin tolerance in S. aureus could be related to the enhanced secretion of an autolysin inhibitor, such as lipoteichoic acid.
D001433:Bacteriolysis / Q000187:drug effects*; D005990:Glycerol / Q000378:metabolism; D008070:Lipopolysaccharides; D010068:Oxacillin / Q000494:pharmacology*; D010403:Penicillin Resistance; D010641:Phenotype; D010712:Phosphatidic Acids / Q000378:metabolism; D013211:Staphylococcus aureus / Q000187:drug effects*; D013682:Teichoic Acids / Q000378:metabolism
D008070:Lipopolysaccharides; D010712:Phosphatidic Acids; D013682:Teichoic Acids; C009900:lipoteichoic acid; D005990:Glycerol; D010068:Oxacillin
Can J Biochem Physiol. 1959 Aug;37(8):911-7
13671378
J Clin Invest. 1978 Mar;61(3):671-7
346604
Antimicrob Agents Chemother. 1977 May;11(5):888-96
879739
Lancet. 1977 Feb 26;1(8009):443-7
65561
Antimicrob Agents Chemother. 1978 Feb;13(2):293-301
25617
Antimicrob Agents Chemother. 1978 Jun;13(6):1052-7
249263
Infect Immun. 1978 Oct;22(1):107-18
730344
Antimicrob Agents Chemother. 1976 Oct;10(4):707-12
984804
Science. 1975 Mar 28;187(4182):1161-7
46620
Biochem Biophys Res Commun. 1975 Dec 1;67(3):1128-35
1027
Proc Natl Acad Sci U S A. 1975 May;72(5):1690-4
239401
Antimicrob Agents Chemother. 1974 Dec;6(6):825-30
4498775
Carbohydr Res. 1975 Mar;40(1):41-52
804992
Can J Microbiol. 1975 Nov;21(11):1692-7
1201514
J Biol Chem. 1969 Aug 25;244(16):4406-12
5806584